CLINICAL THYROIDOLOGY FOR THE PUBLIC
A publication of the American Thyroid Association
Welcome to another issue of Clinical Thyroidology for the Public. In this journal, we will bring to you the most up-to-date, cutting edge thyroid research. We will be providing summaries of research studies that were discussed in a recent issue of Clinical Thyroidology, a publication of the American Thyroid Association for physicians. These summaries are present in lay language to allow the rapid dissemination of thyroid research to the widest possible audience. This means that you are getting the latest information on thyroid research and treatment almost as soon as your physicians. As always, we are happy to entertain any suggestions to improve Clinical Thyroidology for the Public so let us know what you want to see.
We also provide even faster updates of late-breaking thyroid news through Twitter at @thyroidfriends and on Facebook. Our goal is to provide patients with the tools to be the most informed thyroid patient in the waiting room.
Also check out our friends in the Alliance for Thyroid Patient Education. The Alliance member groups consist of: the American Thyroid Association, Bite Me Cancer, the Graves’ Disease and Thyroid Foundation, the Light of Life Foundation, ThyCa: Thyroid Cancer Survivors Association, Thyroid Cancer Canada and Thyroid Federation International.
April is Hashimotos Disease Awareness Month.
In this issue, the studies ask the following questions:
- What are the risk factors for death in patients with myxedema coma?
- Does hyperthyroidism increase the risk of heart problems and death?
- Do thyroid nodules change in size during pregnancy?
- Is ultrasound useful to identify abnormal lymph nodes prior to surgery for thyroid cancer?
- Is the diffuse sclerosing variant of papillary thyroid cancer more aggressive?
- How often is medullary thyroid cancer found in both thyroid lobes in people without hereditary medullary thyroid cancer?
We welcome your feedback and suggestions. Let us know what you want to see in this publication. I hope you find these summaries interesting and informative.
— Alan P. Farwell, MD, FACE